Codes ATC:
A04AA01
EMLc
Indication
Nausea or vomiting
Code ICD11:
MG10
INN
Ondansetron
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
2 mg per mL in 2 mL ampoule (ondansetron base, as hydrochloride)
Oral > Liquid: 4 mg per 5 mL (ondansetron base)
Oral > Solid: 4 mg (ondansetron base) ; 8 mg (ondansetron base) ; 24 mg (ondansetron base) (EML)
Oral > Liquid: 4 mg per 5 mL (ondansetron base)
Oral > Solid: 4 mg (ondansetron base) ; 8 mg (ondansetron base) ; 24 mg (ondansetron base) (EML)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Limite d'âge
> 1 month
Équivalence thérapeutique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that dolasetron, granisetron, palonosetron and tropisetron be specified as therapeutic alternatives under the square box listing for ondansetron on the EML and EMLc.